Characterization of different regimens for initiating anagrelide in patients with essential thrombocythemia who are intolerant or refractory to their current cytoreductive therapy: results from the multicenter FOX study of 177 patients in France

OBJECTIVES: To identify switch modalities used when initiating second- or third-line anagrelide for essential thrombocythemia (ET), assess whether anagrelide is initiated consistently with Summary of Product Characteristics (SPC) recommendations, and determine whether different observed switch regim...

Descripción completa

Detalles Bibliográficos
Autores principales: Rey, Jérôme, Viallard, Jean-François, Keddad, Karim, Smith, Jonathan, Wilde, Paul, Kiladjian, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232889/
https://www.ncbi.nlm.nih.gov/pubmed/24118452
http://dx.doi.org/10.1111/ejh.12210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232889/
https://www.ncbi.nlm.nih.gov/pubmed/24118452
http://dx.doi.org/10.1111/ejh.12210

Ejemplares similares